Aquaculture Vaccines Market To Reach $396.1 Million By 2033

Aquaculture Vaccines Market Growth & Trends

The global aquaculture vaccines market size is estimated to reach USD 396.1 million by 2033, expanding at a CAGR of 7.01% from 2025 to 2033, according to a new report by Grand View Research, Inc. The advent of vaccines for fish has significantly reduced the dependency on antimicrobial agents. Vaccination programs help in protecting the animal health and livelihoods of those who work with livestock as well as aid in ensuring food security. The development of some aquaculture sectors, such as the salmon industry in Norway, wherein fish farmers in the country moved from using antibiotics to vaccines by 1994, demonstrates the potential of vaccines in reducing the dependence on veterinary medicines.

Similar to other markets, the market for aquaculture vaccines has also been significantly affected. Some of the major impacts of COVID-19 on the market include supply chain disruptions, a decline in sales, low demand, growing awareness of animal to human disease transmission risks, and operational hurdles due to changing policies and restrictions.

The growing demand for aquatic animal-derived food products, such as oil, caviar, protein powders, and meat, is encouraging farmers to use vaccinations for aquaculture to gain higher profitability. Due to the rising urbanization, consumers are becoming more aware of the nutritious value of animal protein. The demand for healthy, sustainable, and high-quality meat products that have fewer or no drugs is also increasing rapidly. Thus, the need for healthy breeding of aquatic animals is increasing, which is expected to fuel the demand for aquaculture vaccines, thereby boosting the market growth.

The market for aquaculture vaccines is fairly competitive. The most notable participants in the market are Zoetis; Merck & Co., Inc.; and Elanco, along with other manufacturers of aquaculture vaccines. These players are involved in new product launches, acquisitions, and partnerships to gain a competitive edge over each other. For instance, in July 2020, Zoetis acquired Fish Vet Group from Benchmark Holdings, PLC. This added to the company’s Pharmaq business, which is involved in fish vaccines and services.

 Request a free sample copy or view report summary: Aquaculture Vaccines Market Report

Aquaculture Vaccines Market Report Highlights

• Based on product, the attenuated live vaccines segment led the market with the largest revenue share of 50.13% in 2024.

• By route of administration, the injected segment accounted for the largest market revenue share in 2024, due to its proven efficacy and ability to provide long-lasting, robust immunity in fish.

• The bacterial segment accounted for the largest market revenue share in 2024, primarily due to the high prevalence of bacterial infections in farmed fish, including species such as Aeromonas, Vibrio, and Edwardsiella.

• In 2024, Europe held the largest revenue share owing to the increasing adoption of aquaculture vaccines, especially in countries such as Norway and the U.K.

• North America held the second-largest revenue share in 2024. The key driver in this regional market is the presence of major market players, especially in the U.S.

• Asia Pacific is expected to witness lucrative growth over the forecast period owing to the rise in aquaculture production and favorable government initiatives, especially in developing countries.

Aquaculture Vaccines Market Segmentation

Grand View Research has segmented the global aquaculture vaccines market based on product, application, route of administration, distribution channel, and region:

Aquaculture Vaccines Product Outlook (Revenue, USD Million, 2021 - 2033)

• Attenuated Live Vaccines

• Inactivated Vaccines

• Other Vaccines

Aquaculture Vaccines Route Of Administration Outlook (Revenue, USD Million, 2021 - 2033)

• Oral

• Injected

• Immersion & Spray

Aquaculture Vaccines Application Outlook (Revenue, USD Million, 2021 - 2033)

• Bacterial

• Viral

• Parasitic

Aquaculture Vaccines Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)

• Retail

• E-Commerce

• Hospital/Clinic Pharmacy

Aquaculture Vaccines Region Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • UAE

  • Saudi Arabia

  • Kuwait

  • Qatar

  • Oman

List of Key Players of Aquaculture Vaccines Market

• Zoetis

• Phibro Animal Health Corporation

• Elanco

• Merck & Co., Inc.

• KBNP

• CAVAC

• Kyoto Biken Laboratories, Inc.

• Nisseiken Co., Ltd.

• Vaxxinova International BV

• HIPRA